C. Escott

Emory University

Papers

1

Total Citations

10

H-Index

1

About

Dr. C. Escott is a head and neck surgical oncologist whose research focuses on refining treatment paradigms for oropharyngeal squamous cell carcinoma, particularly through transoral robotic surgery (TORS). Their major contribution centers on de-escalation strategies—specifically, evaluating the safety of omitting intentional primary site radiation after TORS to reduce treatment toxicity without compromising oncologic outcomes. In a landmark 2021 study of 59 patients, Escott demonstrated zero local-regional failures when primary site radiation was omitted, while quantifying nontargeted dose to the surgical bed. This work, with 10 citations, challenges conventional combined-modality approaches and has influenced de-intensification protocols. Escott’s research bridges surgical oncology and radiation oncology, offering patients reduced morbidity from unnecessary radiotherapy. Their findings are particularly impactful for HPV-positive oropharyngeal cancer, where de-escalation is a priority. By providing evidence that TORS alone can achieve excellent locoregional control in carefully selected patients, Escott has advanced personalized, function-preserving treatment in head and neck cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No <scp>local‐regional</scp> failures
10 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Emory University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago